Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020

NESS ZIONA, Israel, Oct. 06, 2016 -- (Healthcare Sales & Marketing Network) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today the extension of the strategic partnership with Shire plc... Biopharmaceuticals, Distribution, Licensing Kamada, Shire plc, GLASSIA, emphysema
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news